Nature Communications (Nov 2017)

Prevalence and detection of low-allele-fraction variants in clinical cancer samples

  • Hyun-Tae Shin,
  • Yoon-La Choi,
  • Jae Won Yun,
  • Nayoung K. D. Kim,
  • Sook-Young Kim,
  • Hyo Jeong Jeon,
  • Jae-Yong Nam,
  • Chung Lee,
  • Daeun Ryu,
  • Sang Cheol Kim,
  • Kyunghee Park,
  • Eunjin Lee,
  • Joon Seol Bae,
  • Dae Soon Son,
  • Je-Gun Joung,
  • Jeeyun Lee,
  • Seung Tae Kim,
  • Myung-Ju Ahn,
  • Se-Hoon Lee,
  • Jin Seok Ahn,
  • Woo Yong Lee,
  • Bo Young Oh,
  • Yeon Hee Park,
  • Jeong Eon Lee,
  • Kwang Hyuk Lee,
  • Hee Cheol Kim,
  • Kyoung-Mee Kim,
  • Young-Hyuck Im,
  • Keunchil Park,
  • Peter J. Park,
  • Woong-Yang Park

DOI
https://doi.org/10.1038/s41467-017-01470-y
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 10

Abstract

Read online

High-throughput sequencing is used to identify somatic variants in cancer patients. Here, the authors perform panel-based profiling of 5095 clinical samples and demonstrate that many clinically-actionable variants have low variant allele fractions, requiring assays with high detection sensitivity.